 Eidos Therapeutics Inc NASDAQ:EIDX has been assigned a consensus recommendation of Buy from the eight research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have issued a buy recommendation on the company. The average 1-year ... 